Quick Takeaways
- James M. Daly has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,726,492.
- Recent insider filing activity is available below.
Insider Trading & Ownership of James M. Daly
- Location
- Wilmington, DE
- Summary
- The estimated net worth of James M. Daly is at least $1,726,492 dollars as of 15 Apr 2026. James M. Daly is the Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $738.1K. James M. Daly is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $713.4K. James M. Daly is the Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $249.4K. James M. Daly is the Director of CYTOKINETICS INC and owns shares of CYTOKINETICS INC (CYTK) stock worth about $25.6K.
- Signature
- /s/ John O. Faurescu, attorney-in-fact for Mr. Daly
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow James M. Daly and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: HALOZYME THERAPEUTICS, INC. ($738,108).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of James M. Daly
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Director | $738,108 | 11 Aug 2023 | ||
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Director | $713,414 | 20 Jun 2025 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | Director | $249,397 | -$670,983 | -73% | 10 Nov 2025 |
| CYTK | CYTOKINETICS INC | Director | $25,573 | 15 Apr 2026 | ||
| BLCM | BELLICUM PHARMACEUTICALS, INC | Director | 03 Jan 2023 |
Insider Transactions Reported by James M. Daly:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.